Academic Journal
Benefit from dose-dense adjuvant chemotherapy for breast cancer: subgroup analyses from the randomised phase 3 PANTHER trial.
العنوان: | Benefit from dose-dense adjuvant chemotherapy for breast cancer: subgroup analyses from the randomised phase 3 PANTHER trial. |
---|---|
المؤلفون: | Matikas, Alexios, Papakonstantinou, Andri, Loibl, Sibylle, Steger, Günther G, Untch, Michael, Johansson, Hemming, Tsiknakis, Nikos, Hellström, Mats, Greil, Richard, Möbus, Volker, Gnant, Michael, Bergh, Jonas, Foukakis, Theodoros |
المصدر: | Lancet Reg Health Eur ; ISSN:2666-7762 ; Volume:49 |
بيانات النشر: | PubMed Central |
سنة النشر: | 2025 |
المجموعة: | PubMed Central (PMC) |
مصطلحات موضوعية: | Adjuvant chemotherapy, Amenorrhea, Breast cancer, Dose-dense, PREDICT, STEPP |
الوصف: | It is unclear whether some patients with high-risk breast cancer do not warrant adjuvant dose-dense chemotherapy due to small expected absolute benefit. |
نوع الوثيقة: | article in journal/newspaper |
اللغة: | English |
Relation: | https://doi.org/10.1016/j.lanepe.2024.101162; https://pubmed.ncbi.nlm.nih.gov/39703564; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11652897/ |
DOI: | 10.1016/j.lanepe.2024.101162 |
الاتاحة: | https://doi.org/10.1016/j.lanepe.2024.101162 https://pubmed.ncbi.nlm.nih.gov/39703564 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11652897/ |
Rights: | © 2024 The Author(s). |
رقم الانضمام: | edsbas.24A1116 |
قاعدة البيانات: | BASE |
DOI: | 10.1016/j.lanepe.2024.101162 |
---|